Introduction: Ovarian tumours are a heterogenous group of neoplasms which account for one of the top five gynaecological malignancies in Indian women. The WHO classification of ovarian tumours is based on morphology with the recent molecular studies supporting the morphology based classification system. Ovarian neoplasms manifest at a late stage either stage 3 or 4 as the symptoms are delayed and non specific and even imaging modalities can be misleading and cytology has its own limitations, hence histopathology diagnosis remains the main stay in achieving an optimum treatment response. Material and methods: This is a¬ two year retrospective study carried out between December 2017 to December 2019 in the department of Pathology, Govt Medical College, Jammu. A total of 62 cases of ovarian tumours were studied. Non neoplastic lesions were excluded from the study. Gross examinations of the specimen along with clinical details were also taken into account for the final diagnosis given on H&E stained slides. All the ovarian tumours were classified based on WHO classification. Results: Out of the total 62 ovarian tumours majority 47 (75.80%) were benign, 10 (16.10%) were malignant and 5 (8.10%) borderline. Age ranged from 13 to 70 years. Surface epithelial tumours (SET) were the commonest 39 (62.90%) followed by Germ cell tumours 19 (30.65%). Benign serous cyst was the commonest ovarian tumour among the SET and mature cystic teratoma in the Germ cell tumours. In the malignant category Papillary serous cystadenocarcinoma was the commonest followed by mucinous cyst adenocarcinoma. Conclusion: A correct histomorphological diagnosis of ovarian tumours help gynaecologist in proper treatment of the patient and in institutes with limited provision of resources, histopathological study remains the gold standard.